Fred Nichols, DO
Obstetrics & Gynecology · Perth Amboy, NJNPI 1982677233
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $500 of the $623 with a category attached, or 80.2%. Johnson & Johnson accounts for 80.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $500 and has fallen 95.2% since, to $24 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in NJ, where the typical reported total is $534.
Across 9 payments — averaging $69.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$500
- AbbVie$31
- Organon$24
- Smith+Nephew$21
- Lupin Inc.$14
- Therapeuticsmd, Inc.$12
- plus $21 from 2 others
What the payments were for
- Consulting fees$50080%
- Food & beverage$12320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $500 |
| AbbVie | 2 | $31 |
| Organon | 1 | $24 |
| Smith+Nephew | 1 | $21 |
| Lupin Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Alydia Health | 1 | $9 |
How this compares
$623 in reported general payments places this provider in the 50th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 28 | $11,126 |
| PremarinEstrogens, Conjugated | 15 | $4,659 |
| Medroxyprogesterone Acetate | 21 | $645 |
| Estradiol | 15 | $244 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $182 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $106 |
| Prednisone | 28 | $73 |
| Azithromycin | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Perth Amboy
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.